Dermata Therapeutics Inc.
(DRMA)
undefined
undefined%
At close: undefined
1.06
-3.64%
Pre-market Dec 16, 2024, 08:22 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -7.79M | -9.61M | -7.90M | -3.24M | -4.72M |
| Depreciation & Amortization | - | - | - | 322.00 | 1.35K |
| Stock-Based Compensation | 522.08K | 930.33K | 1.91M | - | 730.96 |
| Other Working Capital | 494.35K | -135.03K | -121.42K | -522.94K | -197.41K |
| Other Non-Cash Items | - | 930.33K | 14.13K | -36.49K | 872.72K |
| Deferred Income Tax | - | - | - | - | -730.96 |
| Change in Working Capital | 863.68K | -153.58K | 289.55K | -755.85K | -74.99K |
| Operating Cash Flow | -6.41M | -8.83M | -5.69M | -4.03M | -3.92M |
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Purchase of Investments | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | - | - |
| Other Investing Acitivies | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - |
| Debt Repayment | - | - | 1.01M | -676.59K | -626.17K |
| Common Stock Repurchased | -40 | - | -1.00M | - | - |
| Dividend Paid | - | - | - | - | - |
| Other Financial Acitivies | 187.00 | 287.00 | -430.00K | 3.24M | 5.36M |
| Financial Cash Flow | 7.61M | 4.28M | 15.96M | 2.57M | 4.73M |
| Net Cash Flow | 1.20M | -4.56M | 10.27M | -1.46M | 812.19K |
| Free Cash Flow | -6.41M | -8.83M | -5.69M | -4.03M | -3.92M |